News 25. Okt. 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 04. Dez. 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
News 23. Okt. 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News 26. Mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 18. Okt. 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 11. Okt. 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
News 29. Sep 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Success stories 25. Mai 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
News 19. Mai 2022 Kodiak Sciences inaugurates its purpose-built bioconjugation facility in Visp To support potential commercial manufacture of its KSI-301 candidate, Kodiak Sciences has launched a purpose-built bioconjugation facility in Lon...
Success stories 09. Juni 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
News 20. Febr. 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
ニュース 28. Febr. 2022 AIスキルの強化で組織力アップへ AI Master Class を提供中 AI、データ、自動化スキル、経営幹部スキルを発展させたい方は、ぜひAI Master Class オンラインプログラムをご活用ください。
News 11. Mai 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
Aktuell 24. Sep 2021 Lonza baut neue Abfüllanlage in Stein Lonza investiert in die Entwicklung und Herstellung von Arzneimitteln in der Schweiz. Der Pharmazulieferer errichtet in Stein eine neue Abfüllanl...
News 14. Dez. 2021 Pharma group Siegfried invests in Valais and creates 40 jobs Siegfried will build a research and development laboratory in Evionnaz, an investment of tens of millions of Swiss francs resulting in the creati...
News 24. Sep 2021 Lonza builds new filling line in Stein Lonza is investing in the development and manufacture of medicinal products in Switzerland. The pharmaceutical supplier is constructing a new fil...
News 10. Mai 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...